CellMax Garners $14,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1aacf1c0-00be-4a97-9139-a6ab9d865c6a - Date
7/27/2016 - Company Name
CellMax - Mailing Address
1271 Oakmead Parkway Sunnyvale, CA 94085 USA - Company Description
CellMax Assure helps your patients understand and manage their hereditary risk for cancer. Offering a broad menu of testing options and access to a personalized risk management program, CellMax Assure enables you to support your patients with easy, convenient cancer risk testing. - Website
http://www.cellmaxlife.com - Transaction Type
Venture Equity - Transaction Amount
$14,000,000 - Transaction Round
Series A - Proceeds Purposes
The new $9M in funding is being used for continued product development, ongoing clinical trials, and commercialization of the full range of blood tests, including genetic cancer risk detection, and early cancer detection for colorectal and other cancers. - M&A Terms
- Venture Investor
Artiman Ventures - Venture Investor
Investor - Venture Investor
Undisclosed
